Oxurion NV (EBR:OXUR)
Belgium · Delayed Price · Currency is EUR 0.0024
0.00 (0.00%)
Jul 21, 2026, 2:23 PM CET
Oxurion NV Revenue
In the year 2025, Oxurion NV had annual revenue of 555.00K EUR with 18,400.00% growth.
Revenue
555.00K
Revenue Growth
+18,400.00%
P/S Ratio
0.38
Revenue / Employee
21.35K
Employees
26
Market Cap
212.86K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 555.00K | 552.00K | 18,400.00% |
| Dec 31, 2024 | 3.00K | -260.00K | -98.86% |
| Dec 31, 2023 | 263.00K | -332.00K | -55.80% |
| Dec 31, 2022 | 595.00K | -533.00K | -47.25% |
| Dec 31, 2021 | 1.13M | -950.00K | -45.72% |
| Dec 31, 2020 | 2.08M | -1.87M | -47.34% |
| Dec 31, 2019 | 3.95M | -1.37M | -25.83% |
| Dec 31, 2018 | 5.32M | -3.74M | -41.25% |
| Dec 31, 2017 | 9.06M | 1.95M | 27.46% |
| Dec 31, 2016 | 7.10M | -4.09M | -36.56% |
| Dec 31, 2015 | 11.20M | -2.58M | -18.71% |
| Dec 31, 2014 | 13.78M | -99.01M | -87.79% |
| Dec 31, 2013 | 112.78M | 37.68M | 50.16% |
| Dec 31, 2012 | 75.11M | 72.63M | 2,933.32% |
| Dec 31, 2011 | 2.48M | -3.70M | -59.90% |
| Dec 31, 2010 | 6.18M | 1.96M | 46.57% |
| Dec 31, 2009 | 4.21M | -26.21M | -86.15% |
| Dec 31, 2008 | 30.42M | 28.92M | 1,924.02% |
| Dec 31, 2007 | 1.50M | -1.74M | -53.65% |
| Dec 31, 2006 | 3.24M | -2.75M | -45.84% |
| Dec 31, 2005 | 5.99M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 7.74B |
| argenx SE | 4.11B |
| European Medical Solutions | 52.80M |
| Hyloris Pharmaceuticals | 7.94M |
| Onward Medical | 5.41M |
| Celyad Oncology | 21.00K |
| Financière de Tubize | 13.26K |
| BioSenic | -2.39M |